Roche Scoops Up Verum Diagnostica

Law360, New York (December 5, 2011, 2:35 PM EST) -- Swiss pharmaceutical and diagnostics giant F. Hoffmann-La Roche Ltd. will acquire Verum Diagnostica GmbH for at least $14.8 million to help grow its blood clotting testing business, Roche announced Monday.

Roche will pay shareholders of the German company — a wholly owned subsidiary of Dynabyte Informationssysteme GmbH — $14.8 million and potentially $2.7 million more based on certain performance-related milestones, according to the company. The deal is expected to close in January.

Munich-based Verum Diagnostica makes the Multiplate analyzer for testing the functioning of blood platelets,...
To view the full article, register now.